The Spanish Patent and Trademark Office has conceded to Devicare the patent for the use of theobromine and its derivatives for the treatment and prevention of frequent urological pathologies related to urinary pH such as renal and urinary lithiasis (kidney stones), that affects more than 2.2 million people in Spain, besides the 325,000 new cases that are diagnosed every year according to data from the Ministry of Health.
Last news about Devicare
Barcelona’s footballer Luis Suarez is sponsoring the 12th edition of the “Relats solidaris de l’esport”. This book is a non-profit solidary initiative of a group of journalists to raise financial resources to charitable causes and can be purchased at the bookstore of El Corte Inglés for only 10 €. At the present edition the money raised from the sales of this solidarity book will go to the Catalan Association of Hereditary Metabolic Disorders, who will allocate the funds for the PKU research.
Devicare is pleased to announce that the Pharmacy JM Muntané (c/Espronceda 308, Barcelona), has sold the first unit of Lit-Control pH Meter medical device. The Pharmacy JM Muntané has incorporated recently the new method called Lit-Control indicated for in home prevention of kidney stones in their internal procedures and on its website for selling it online through the following link: www.farmaciajmmuntane.com
Devicare and M4 Pharma Laboratories will present on premiere the Lit-Control pH Meter medical device during the XXVI National Meeting of the Lithiasis and Endourological, Laparoscopy and Robotics Groups from the AEU, held in Sabadell during the 28th and 29th of January.
Entrevista a Rosendo Garganta , Director general y fundador de Devicare en Biocat A Rosendo Garganta el espíritu emprendedor le viene de pequeño: proviene de una familia de empresarios en el ámbito de la salud.
La pasada semana (5-9 Octubre) tuvo lugar la StartUp Week de Sanofi con el programa Health-U, orientado a mejorar la calidad de vida de los afectados por hipercolesterolemia.
Durante los días 10-12 de Septiembre, Devicare asistió al 3er congreso EULIS15, realizado en Alicante, y organizado por el grupo de Urolitiasis de la Asociación Europea de Urología.